UK investment in Gavi, the Vaccine Alliance (2016-2020)
Description
Gavi supports vaccine delivery in 68 of the world's poorest countries reaching 60% of the world's birth cohort. Gavi immunises children against vaccine preventable diseases including measles, rubella, meningitis, cervical cancer, pneumonia and diarrhoea. Gavi has played a significant role in the recent halving of global child mortality. Over the 2016 to 2020, Gavi will fully deliver the UK target to immunise 76 million children and save 1.4 million lives. Gavi targets reaching those in hard to reach areas, the poorest, and the most marginalised. Gavi has a major global market shaping role for vaccines, negotiating lower prices for low-income countries, and incentivising new vaccines such as for Ebola and Malaria.
Location
The country, countries or regions that benefit from this Programme.
Status Completion
The current stage of the Programme, consistent with the International Aid Transparency Initiative's (IATI) classifications.
Programme Spend
Programme budget and spend to date, as per the amounts loaded in financial system(s), and for which procurement has been finalised.
Participating Organisation(s)
Help with participating organisations
Accountable:Organisation responsible for oversight of the activity
Extending: Organisation that manages the budget on behalf of the funding organisation.
Funding: Organisation which provides funds.
Implementing: Organisations implementing the activity.
- Accountable
- Funding
- Implementing
Sectors
Sector groups as a percentage of total Programme budget according to the OECD Development Assistance Committee (DAC) classifications.
Budget
A comparison across financial years of forecast budget and spend to date on the Programme.
Policy Marker(s)
ODA measures in relation to their realisation of OECD development policy objectives